The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has published figures saying that Europeans spent at least 11.6 billion euros ($12.7 billion) in 2017 on illegal cannabis purchases, confirming marijuana as the largest drugs market in the 28-country European Union.

US News reports

In its annual report, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) said the EU’s overall narcotics market was worth at least 30 billion euros in 2017, up from 24 billion in 2013.

The global market for illicit drugs was estimated to be worth between $426 and $652 billion, the agency said, warning that its estimates about the EU market were conservative.

Illegal sales of herbal cannabis and its resin represented 39% of the EU’s drugs market, up from 38% in 2013, with revenues for criminal organizations dwarfing those in legal markets.

Read the full news report

Supply for the EU comes from Morocco, Albania and even as far away as California, the  EMCDDA has  noted.

EU Drug Markets Report 2019


Series type: Joint publications


The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis presented in this report spans numerous topics such as the links between drugs and other crimes, the licit economy and society more generally as well as the processes and players involved in the trade, from production and trafficking to distribution. Taking an evidence-based approach, the report reviews the markets for heroin, cocaine, cannabis, amphetamine, methamphetamine, MDMA and new psychoactive substances. It also provides action points to inform policy development at EU and national level. This publication is an essential reference for law enforcement professionals, policymakers, the academic community and indeed for anyone seeking up-to-date information and analysis on drug markets in Europe.

Take our survey

Feedback from our audiences is very valuable in the process of constantly improving our products and services. This is why we would like to invite you to answer our short survey on the EU Drug Markets Report 2019. Please spare a few minutes to help us better understand your needs. Go to the survey >>